Lewis calls for quick action on Right to Try
WASHINGTON, D.C. - Congressman Jason Lewis (MN-02) issued the following statement after calling on House Leadership to schedule a vote on the Right to Try Act, S. 204:
“I want each and every treatment option that could save a life to be available to those who are sick. ‘Right to Try’ would do that, by making drugs that have passed safety tests an option in treatment plans for people who are seriously unwell, even if they haven’t quite completed the arduous FDA approval process. The Senate passed Right to Try unanimously last summer. That’s why I joined many of my colleagues in calling for a vote in the House as soon as possible. Families are depending on us.”
Background: The Right to Try Act was introduced in the House on February 7, 2017 to give patients a chance to receive treatments that haven’t yet completed the years-long FDA approval process. Rep. Lewis was an original cosponsor. These drugs have passed safety tests and offer benefits that outweigh the risks for the terminally ill. Right to Try is law in 38 states, including Minnesota, and this bill would make sure that the FDA respects state law while maintaining safeguards, such as physician certification. The letter is attached.